{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:06:29Z","timestamp":1793315189638,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00198-022-06482-z","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T23:02:58Z","timestamp":1658185378000},"page":"2467-2478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Gaps and alternative surgical and non-surgical approaches in the bone fragility management: an updated review"],"prefix":"10.1007","volume":"33","author":[{"given":"Umberto","family":"Tarantino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Cariati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Greggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Iundusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gasbarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Iolascon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina E.","family":"Akesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Bouxsein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Tranquilli Leali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Civinini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Falez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"6482_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10195-017-0474-7","volume":"18","author":"U Tarantino","year":"2017","unstructured":"Tarantino U, Iolascon G, Cianferotti L et al (2017) Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology. J Orthop Traumatol Off J Ital Soc Orthop Traumatol 18:3\u201336. https:\/\/doi.org\/10.1007\/s10195-017-0474-7","journal-title":"J Orthop Traumatol Off J Ital Soc Orthop Traumatol"},{"key":"6482_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11739-018-1874-2","volume":"14","author":"R Nuti","year":"2019","unstructured":"Nuti R, Brandi ML, Checchia G et al (2019) Guidelines for the management of osteoporosis and fragility fractures. Intern Emerg Med 14:85\u2013102. https:\/\/doi.org\/10.1007\/s11739-018-1874-2","journal-title":"Intern Emerg Med"},{"key":"6482_CR3","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","volume":"289","author":"K Wolf-Maier","year":"2003","unstructured":"Wolf-Maier K, Cooper RS, Banegas JR et al (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289:2363\u20132369. https:\/\/doi.org\/10.1001\/jama.289.18.2363","journal-title":"JAMA"},{"key":"6482_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s001980070064","volume":"11","author":"JA Kanis","year":"2000","unstructured":"Kanis JA, Johnell O, Oden A et al (2000) Long-term risk of osteoporotic fracture in Malm\u00f6. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 11:669\u2013674. https:\/\/doi.org\/10.1007\/s001980070064","journal-title":"Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR5","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s00198-012-1964-3","volume":"23","author":"JA Kanis","year":"2012","unstructured":"Kanis JA, Od\u00e9n A, McCloskey EV et al (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int a J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 23:2239\u20132256. https:\/\/doi.org\/10.1007\/s00198-012-1964-3","journal-title":"Osteoporos Int a J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5312\/wjo.v7.i3.171","volume":"7","author":"P Pisani","year":"2016","unstructured":"Pisani P, Renna MD, Conversano F et al (2016) Major osteoporotic fragility fractures: risk factor updates and societal impact. World J Orthop 7:171\u2013181. https:\/\/doi.org\/10.5312\/wjo.v7.i3.171","journal-title":"World J Orthop"},{"key":"6482_CR7","doi-asserted-by":"publisher","first-page":"19596","DOI":"10.3402\/ijch.v72i0.19596","volume":"72","author":"A Jakobsen","year":"2013","unstructured":"Jakobsen A, Laurberg P, Vestergaard P, Andersen S (2013) Clinical risk factors for osteoporosis are common among elderly people in Nuuk. Greenland Int J Circumpolar Health 72:19596. https:\/\/doi.org\/10.3402\/ijch.v72i0.19596","journal-title":"Greenland Int J Circumpolar Health"},{"key":"6482_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s001980170112","volume":"12","author":"JA Kanis","year":"2001","unstructured":"Kanis JA, Oden A, Johnell O et al (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA 12:417\u2013427. https:\/\/doi.org\/10.1007\/s001980170112","journal-title":"Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jclinepi.2010.07.007","volume":"64","author":"AH Warriner","year":"2011","unstructured":"Warriner AH, Patkar NM, Curtis JR et al (2011) Which fractures are most attributable to osteoporosis? J Clin Epidemiol 64:46\u201353. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.07.007","journal-title":"J Clin Epidemiol"},{"key":"6482_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00198-016-3868-0","volume":"28","author":"H Johansson","year":"2017","unstructured":"Johansson H, Siggeirsd\u00f3ttir K, Harvey NC et al (2017) Imminent risk of fracture after fracture. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 28:775\u2013780. https:\/\/doi.org\/10.1007\/s00198-016-3868-0","journal-title":"Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/ard.2008.092775","volume":"68","author":"TACM van Geel","year":"2009","unstructured":"van Geel TACM, van Helden S, Geusens PP et al (2009) Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis 68:99\u2013102. https:\/\/doi.org\/10.1136\/ard.2008.092775","journal-title":"Ann Rheum Dis"},{"key":"6482_CR12","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00198-018-4502-0","volume":"29","author":"JA Kanis","year":"2018","unstructured":"Kanis JA, Johansson H, Od\u00e9n A et al (2018) Characteristics of recurrent fractures. Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA 29:1747\u20131757. https:\/\/doi.org\/10.1007\/s00198-018-4502-0","journal-title":"Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-019-05176-3","volume":"31","author":"JA Kanis","year":"2020","unstructured":"Kanis JA, Harvey NC, McCloskey E et al (2020) Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 31:1\u201312. https:\/\/doi.org\/10.1007\/s00198-019-05176-3","journal-title":"Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR14","doi-asserted-by":"publisher","unstructured":"Rocha VM, Gaspar HA, Oliveira CF de (2018) Fracture risk assessment in home care patients using the FRAX\u00ae tool. Einstein (Sao Paulo) 16:eAO4236. https:\/\/doi.org\/10.1590\/S1679-45082018AO4236","DOI":"10.1590\/S1679-45082018AO4236"},{"key":"6482_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/09513590.2017.1407308","volume":"34","author":"G Bonaccorsi","year":"2018","unstructured":"Bonaccorsi G, Messina C, Cervellati C et al (2018) Fracture risk assessment in postmenopausal women with diabetes: comparison between DeFRA and FRAX tools. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 34:404\u2013408. https:\/\/doi.org\/10.1080\/09513590.2017.1407308","journal-title":"Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol"},{"key":"6482_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","volume":"15","author":"F Borgstr\u00f6m","year":"2020","unstructured":"Borgstr\u00f6m F, Karlsson L, Orts\u00e4ter G et al (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15:59. https:\/\/doi.org\/10.1007\/s11657-020-0706-y","journal-title":"Arch Osteoporos"},{"key":"6482_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00198-017-4317-4","volume":"29","author":"A Svedbom","year":"2018","unstructured":"Svedbom A, Borgst\u00f6m F, Hernlund E et al (2018) Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 29:557\u2013566. https:\/\/doi.org\/10.1007\/s00198-017-4317-4","journal-title":"Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR18","doi-asserted-by":"publisher","first-page":"e2027584","DOI":"10.1001\/jamanetworkopen.2020.27584","volume":"3","author":"K Ito","year":"2020","unstructured":"Ito K (2020) Cost-effectiveness of screening for osteoporosis in older men with a history of falls. JAMA Netw open 3:e2027584. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.27584","journal-title":"JAMA Netw open"},{"key":"6482_CR19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s11136-017-1748-5","volume":"27","author":"A Svedbom","year":"2018","unstructured":"Svedbom A, Borgstr\u00f6m F, Hernlund E et al (2018) Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS. Qual Life Res Int J Qual Life Asp Treat Care Rehabil 27:707\u2013716. https:\/\/doi.org\/10.1007\/s11136-017-1748-5","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"key":"6482_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00198-012-2240-2","volume":"24","author":"F Borgstr\u00f6m","year":"2013","unstructured":"Borgstr\u00f6m F, Lekander I, Iverg\u00e5rd M et al (2013) The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)\u2013quality of life during the first 4 months after fracture. Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA 24:811\u2013823. https:\/\/doi.org\/10.1007\/s00198-012-2240-2","journal-title":"Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR21","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00198-017-3976-5","volume":"28","author":"C Roux","year":"2017","unstructured":"Roux C, Briot K (2017) Imminent fracture risk. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 28:1765\u20131769. https:\/\/doi.org\/10.1007\/s00198-017-3976-5","journal-title":"Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11657-016-0280-5","volume":"11","author":"M Bonafede","year":"2016","unstructured":"Bonafede M, Shi N, Barron R et al (2016) Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data. Arch Osteoporos 11:26. https:\/\/doi.org\/10.1007\/s11657-016-0280-5","journal-title":"Arch Osteoporos"},{"key":"6482_CR23","first-page":"2228","volume":"46","author":"HG McKercher","year":"2000","unstructured":"McKercher HG, Crilly RG, Kloseck M (2000) Osteoporosis management in long-term care. Survey of Ontario physicians. Can Fam Physician 46:2228\u20132235","journal-title":"Can Fam Physician"},{"key":"6482_CR24","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/ageing\/afr085","volume":"40","author":"S Kaffashian","year":"2011","unstructured":"Kaffashian S, Raina P, Oremus M et al (2011) The burden of osteoporotic fractures beyond acute care: the Canadian Multicentre Osteoporosis Study (CaMos). Age Ageing 40:602\u2013607. https:\/\/doi.org\/10.1093\/ageing\/afr085","journal-title":"Age Ageing"},{"key":"6482_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","volume":"8","author":"E Hernlund","year":"2013","unstructured":"Hernlund E, Svedbom A, Iverg\u00e5rd M et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136. https:\/\/doi.org\/10.1007\/s11657-013-0136-1","journal-title":"Arch Osteoporos"},{"key":"6482_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11657-020-00816-2","volume":"15","author":"YT Chau","year":"2020","unstructured":"Chau YT, Nashi N, Law LS-C et al (2020) Undertreatment of osteoporosis following hip fracture: a retrospective, observational study in Singapore. Arch Osteoporos 15:141. https:\/\/doi.org\/10.1007\/s11657-020-00816-2","journal-title":"Arch Osteoporos"},{"key":"6482_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11657-018-0430-z","volume":"13","author":"AM Rodrigues","year":"2018","unstructured":"Rodrigues AM, Eus\u00e9bio M, Santos MJ et al (2018) The burden and undertreatment of fragility fractures among senior women. Arch Osteoporos 13:22. https:\/\/doi.org\/10.1007\/s11657-018-0430-z","journal-title":"Arch Osteoporos"},{"key":"6482_CR28","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/jbmr.2202","volume":"29","author":"DH Solomon","year":"2014","unstructured":"Solomon DH, Johnston SS, Boytsov NN et al (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J bone Miner Res Off J Am Soc Bone Miner Res 29:1929\u20131937. https:\/\/doi.org\/10.1002\/jbmr.2202","journal-title":"J bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"6482_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.amjmed.2015.01.014","volume":"128","author":"SC Kim","year":"2015","unstructured":"Kim SC, Kim M-S, Sanf\u00e9lix-Gimeno G et al (2015) Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med 128:519\u201326.e1. https:\/\/doi.org\/10.1016\/j.amjmed.2015.01.014","journal-title":"Am J Med"},{"key":"6482_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00774-012-0349-1","volume":"30","author":"CA Inderjeeth","year":"2012","unstructured":"Inderjeeth CA, Chan K, Kwan K, Lai M (2012) Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments. J Bone Miner Metab 30:493\u2013503. https:\/\/doi.org\/10.1007\/s00774-012-0349-1","journal-title":"J Bone Miner Metab"},{"key":"6482_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","volume":"5","author":"HG Bone","year":"2017","unstructured":"Bone HG, Wagman RB, Brandi ML et al (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 5:513\u2013523. https:\/\/doi.org\/10.1016\/S2213-8587(17)30138-9","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6482_CR32","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1007\/s00198-019-05020-8","volume":"30","author":"JP Bilezikian","year":"2019","unstructured":"Bilezikian JP, Lin CJF, Brown JP et al (2019) Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 30:1855\u20131864. https:\/\/doi.org\/10.1007\/s00198-019-05020-8","journal-title":"Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR33","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1210\/jc.2019-00271","volume":"104","author":"S Ferrari","year":"2019","unstructured":"Ferrari S, Butler PW, Kendler DL et al (2019) Further nonvertebral fracture reduction beyond 3 years for up to 10 years of denosumab treatment. J Clin Endocrinol Metab 104:3450\u20133461. https:\/\/doi.org\/10.1210\/jc.2019-00271","journal-title":"J Clin Endocrinol Metab"},{"key":"6482_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/1759720X16650866","volume":"8","author":"A Grey","year":"2016","unstructured":"Grey A (2016) Intravenous zoledronate for osteoporosis: less might be more. Ther Adv Musculoskelet Dis 8:119\u2013123. https:\/\/doi.org\/10.1177\/1759720X16650866","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"6482_CR35","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Col\u00f3n-Emeric CS, Magaziner JS et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799\u20131809. https:\/\/doi.org\/10.1056\/NEJMoa074941","journal-title":"N Engl J Med"},{"key":"6482_CR36","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0140-6736(17)32137-2","volume":"391","author":"DL Kendler","year":"2018","unstructured":"Kendler DL, Marin F, Zerbini CAF et al (2018) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet (London, England) 391:230\u2013240. https:\/\/doi.org\/10.1016\/S0140-6736(17)32137-2","journal-title":"Lancet (London, England)"},{"key":"6482_CR37","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1210\/jc.2014-3718","volume":"100","author":"BZ Leder","year":"2015","unstructured":"Leder BZ, O\u2019Dea LSL, Zanchetta JR et al (2015) Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 100:697\u2013706. https:\/\/doi.org\/10.1210\/jc.2014-3718","journal-title":"J Clin Endocrinol Metab"},{"key":"6482_CR38","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jama.2016.11136","volume":"316","author":"PD Miller","year":"2016","unstructured":"Miller PD, Hattersley G, Riis BJ et al (2016) Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA 316:722\u2013733. https:\/\/doi.org\/10.1001\/jama.2016.11136","journal-title":"JAMA"},{"key":"6482_CR39","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375:1532\u20131543. https:\/\/doi.org\/10.1056\/NEJMoa1607948","journal-title":"N Engl J Med"},{"key":"6482_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/jbmr.3622","volume":"34","author":"EM Lewiecki","year":"2019","unstructured":"Lewiecki EM, Dinavahi RV, Lazaretti-Castro M et al (2019) One year of romosozumab followed by two years of denosumab maintains fracture risk reductions: results of the FRAME extension study. J bone Miner Res Off J Am Soc Bone Miner Res 34:419\u2013428. https:\/\/doi.org\/10.1002\/jbmr.3622","journal-title":"J bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"6482_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00198-006-0230-y","volume":"18","author":"D Weycker","year":"2007","unstructured":"Weycker D, Macarios D, Edelsberg J, Oster G (2007) Compliance with osteoporosis drug therapy and risk of fracture. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 18:271\u2013277. https:\/\/doi.org\/10.1007\/s00198-006-0230-y","journal-title":"Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR42","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/archinte.163.17.2052","volume":"163","author":"SE Andrade","year":"2003","unstructured":"Andrade SE, Majumdar SR, Chan KA et al (2003) Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 163:2052\u20132057. https:\/\/doi.org\/10.1001\/archinte.163.17.2052","journal-title":"Arch Intern Med"},{"key":"6482_CR43","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00198-004-1652-z","volume":"15","author":"JJ Caro","year":"2004","unstructured":"Caro JJ, Ishak KJ, Huybrechts KF et al (2004) The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 15:1003\u20131008. https:\/\/doi.org\/10.1007\/s00198-004-1652-z","journal-title":"Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.maturitas.2004.02.005","volume":"48","author":"JS McCombs","year":"2004","unstructured":"McCombs JS, Thiebaud P, McLaughlin-Miley C, Shi J (2004) Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 48:271\u2013287. https:\/\/doi.org\/10.1016\/j.maturitas.2004.02.005","journal-title":"Maturitas"},{"key":"6482_CR45","doi-asserted-by":"publisher","first-page":"856","DOI":"10.4065\/80.7.856","volume":"80","author":"RR Recker","year":"2005","unstructured":"Recker RR, Gallagher R, MacCosbe PE (2005) Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 80:856\u2013861. https:\/\/doi.org\/10.4065\/80.7.856","journal-title":"Mayo Clin Proc"},{"key":"6482_CR46","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.2106\/JBJS.G.00864","volume":"90","author":"V Rabenda","year":"2008","unstructured":"Rabenda V, Vanoverloop J, Fabri V et al (2008) Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg Am 90:2142\u20132148. https:\/\/doi.org\/10.2106\/JBJS.G.00864","journal-title":"J Bone Joint Surg Am"},{"key":"6482_CR47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00198-003-1544-7","volume":"15","author":"MJM Panneman","year":"2004","unstructured":"Panneman MJM, Lips P, Sen SS, Herings RMC (2004) Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA 15:120\u2013124. https:\/\/doi.org\/10.1007\/s00198-003-1544-7","journal-title":"Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11657-016-0292-1","volume":"11","author":"S Ferrari","year":"2016","unstructured":"Ferrari S, Reginster J-Y, Brandi ML et al (2016) Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture. Arch Osteoporos 11:37. https:\/\/doi.org\/10.1007\/s11657-016-0292-1","journal-title":"Arch Osteoporos"},{"key":"6482_CR49","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00198-019-05183-4","volume":"31","author":"L-L Ding","year":"2020","unstructured":"Ding L-L, Wen F, Wang H et al (2020) Osteoporosis drugs for prevention of clinical fracture in white postmenopausal women: a network meta-analysis of survival data. Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA 31:961\u2013971. https:\/\/doi.org\/10.1007\/s00198-019-05183-4","journal-title":"Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR50","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00198-019-04947-2","volume":"30","author":"J-Y Reginster","year":"2019","unstructured":"Reginster J-Y, Bianic F, Campbell R et al (2019) Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 30:1465\u20131473. https:\/\/doi.org\/10.1007\/s00198-019-04947-2","journal-title":"Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR51","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s00198-020-05378-0","volume":"31","author":"D Cornelissen","year":"2020","unstructured":"Cornelissen D, de Kunder S, Si L et al (2020) Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 31:1645\u20131669. https:\/\/doi.org\/10.1007\/s00198-020-05378-0","journal-title":"Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR52","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s00198-019-05104-5","volume":"30","author":"M Hiligsmann","year":"2019","unstructured":"Hiligsmann M, Cornelissen D, Vrijens B et al (2019) Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeleta. Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA 30:2155\u20132165. https:\/\/doi.org\/10.1007\/s00198-019-05104-5","journal-title":"Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR53","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00223-010-9364-1","volume":"86","author":"B Abrahamsen","year":"2010","unstructured":"Abrahamsen B (2010) Adverse effects of bisphosphonates. Calcif Tissue Int 86:421\u2013435. https:\/\/doi.org\/10.1007\/s00223-010-9364-1","journal-title":"Calcif Tissue Int"},{"key":"6482_CR54","doi-asserted-by":"publisher","first-page":"96","DOI":"10.14310\/horm.2002.1226","volume":"8","author":"PD Papapetrou","year":"2009","unstructured":"Papapetrou PD (2009) Bisphosphonate-associated adverse events. Hormones (Athens) 8:96\u2013110. https:\/\/doi.org\/10.14310\/horm.2002.1226","journal-title":"Hormones (Athens)"},{"key":"6482_CR55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.11005\/jbm.2014.21.2.155","volume":"21","author":"Y Won","year":"2014","unstructured":"Won Y, Lim J-R, Kim Y-H et al (2014) Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate. J bone Metab 21:155\u2013159","journal-title":"J bone Metab"},{"key":"6482_CR56","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1136\/annrheumdis-2013-205080","volume":"73","author":"M Kharazmi","year":"2014","unstructured":"Kharazmi M, Hallberg P, Micha\u00eblsson K (2014) Gender related difference in the risk of bisphosphonate associated atypical femoral fracture and osteonecrosis of the jaw. Ann Rheum Dis 73:1594","journal-title":"Ann Rheum Dis"},{"key":"6482_CR57","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/jbmr.3337","volume":"33","author":"SR Cummings","year":"2018","unstructured":"Cummings SR, Ferrari S, Eastell R et al (2018) Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J bone Miner Res Off J Am Soc Bone Miner Res 33:190\u2013198. https:\/\/doi.org\/10.1002\/jbmr.3337","journal-title":"J bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"6482_CR58","doi-asserted-by":"crossref","unstructured":"Lamy O, Stoll D, Aubry-Rozier B, Gonzalez Rodriguez E (2020) Correction to: Stopping denosumab. Curr Osteoporos Rep","DOI":"10.1007\/s11914-020-00565-8"},{"key":"6482_CR59","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1210\/clinem\/dgab193","volume":"106","author":"BL Langdahl","year":"2021","unstructured":"Langdahl BL, Hofbauer LC, Forfar JC (2021) Cardiovascular safety and sclerostin inhibition. J Clin Endocrinol Metab 106:1845\u20131853. https:\/\/doi.org\/10.1210\/clinem\/dgab193","journal-title":"J Clin Endocrinol Metab"},{"key":"6482_CR60","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s00198-011-1642-x","volume":"22","author":"D Marsh","year":"2011","unstructured":"Marsh D, Akesson K, Beaton DE et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA 22:2051\u20132065. https:\/\/doi.org\/10.1007\/s00198-011-1642-x","journal-title":"Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR61","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00198-013-2348-z","volume":"24","author":"K Akesson","year":"2013","unstructured":"Akesson K, Marsh D, Mitchell PJ et al (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 24:2135\u20132152. https:\/\/doi.org\/10.1007\/s00198-013-2348-z","journal-title":"Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR62","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00198-012-2090-y","volume":"24","author":"K Ganda","year":"2013","unstructured":"Ganda K, Puech M, Chen JS et al (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 24:393\u2013406. https:\/\/doi.org\/10.1007\/s00198-012-2090-y","journal-title":"Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR63","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.2106\/JBJS.L.00223","volume":"96","author":"KMB Huntjens","year":"2014","unstructured":"Huntjens KMB, van Geel TACM, van den Bergh JPW et al (2014) Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality. J Bone Joint Surg Am 96:e29. https:\/\/doi.org\/10.2106\/JBJS.L.00223","journal-title":"J Bone Joint Surg Am"},{"key":"6482_CR64","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00198-018-4411-2","volume":"29","author":"C-H Wu","year":"2018","unstructured":"Wu C-H, Kao I-J, Hung W-C et al (2018) Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature. Osteoporos Int a J Establ as result Coop between Eur Found Osteoporos Natl Osteoporos Found USA 29:1227\u20131242. https:\/\/doi.org\/10.1007\/s00198-018-4411-2","journal-title":"Osteoporos Int a J Establ as result Coop between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR65","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bone.2018.03.018","volume":"111","author":"C-H Wu","year":"2018","unstructured":"Wu C-H, Tu S-T, Chang Y-F et al (2018) Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis. Bone 111:92\u2013100. https:\/\/doi.org\/10.1016\/j.bone.2018.03.018","journal-title":"Bone"},{"key":"6482_CR66","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/jbmr.3699","volume":"34","author":"SR Majumdar","year":"2019","unstructured":"Majumdar SR, Lier DA, McAlister FA et al (2019) Cost-effectiveness of osteoporosis interventions to improve quality of care after upper extremity fracture: results from a randomized trial (C-STOP Trial). J bone Miner Res Off J Am Soc Bone Miner Res 34:1220\u20131228. https:\/\/doi.org\/10.1002\/jbmr.3699","journal-title":"J bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"6482_CR67","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1302\/0301-620X.88B10.17683","volume":"88","author":"PV Giannoudis","year":"2006","unstructured":"Giannoudis PV, Schneider E (2006) Principles of fixation of osteoporotic fractures. J Bone Joint Surg Br 88:1272\u20131278. https:\/\/doi.org\/10.1302\/0301-620X.88B10.17683","journal-title":"J Bone Joint Surg Br"},{"issue":"Suppl 1","key":"6482_CR68","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s40520-013-0135-5","volume":"25","author":"G Iolascon","year":"2013","unstructured":"Iolascon G, Resmini G, Tarantino U (2013) \u201cOsteoporotic fragility fractures: medical and surgical approaches\u201d II National Congress of the Italian Orthopedic Group for the Study of Severe Osteoporosis (GISOOS). Aging Clin Exp Res 25(Suppl 1):S1-2","journal-title":"Aging Clin Exp Res"},{"key":"6482_CR69","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/annrheumdis-2016-210289","volume":"76","author":"WF Lems","year":"2017","unstructured":"Lems WF, Dreinh\u00f6fer KE, Bischoff-Ferrari H et al (2017) EULAR\/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures. Ann Rheum Dis 76:802\u2013810. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210289","journal-title":"Ann Rheum Dis"},{"key":"6482_CR70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5694\/j.1326-5377.2010.tb03400.x","volume":"192","author":"JCS Mak","year":"2010","unstructured":"Mak JCS, Cameron ID, March LM (2010) Evidence-based guidelines for the management of hip fractures in older persons: an update. Med J Aust 192:37\u201341. https:\/\/doi.org\/10.5694\/j.1326-5377.2010.tb03400.x","journal-title":"Med J Aust"},{"issue":"Suppl 2","key":"6482_CR71","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0020-1383(16)47002-6","volume":"47","author":"C von R\u00fcden","year":"2016","unstructured":"von R\u00fcden C, Augat P (2016) Failure of fracture fixation in osteoporotic bone. Injury 47(Suppl 2):S3\u2013S10. https:\/\/doi.org\/10.1016\/S0020-1383(16)47002-6","journal-title":"Injury"},{"key":"6482_CR72","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/145749690609500205","volume":"95","author":"A Moroni","year":"2006","unstructured":"Moroni A, Hoang-Kim A, Lio V, Giannini S (2006) Current augmentation fixation techniques for the osteoporotic patient. Scand J Surg SJS Off organ Finnish Surg Soc Scand Surg Soc 95:103\u2013109. https:\/\/doi.org\/10.1177\/145749690609500205","journal-title":"Scand J Surg SJS Off organ Finnish Surg Soc Scand Surg Soc"},{"key":"6482_CR73","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1080\/14656566.2016.1241765","volume":"17","author":"L Vannucci","year":"2016","unstructured":"Vannucci L, Brandi ML (2016) Healing of the bone with anti-fracture drugs. Expert Opin Pharmacother 17:2267\u20132272. https:\/\/doi.org\/10.1080\/14656566.2016.1241765","journal-title":"Expert Opin Pharmacother"},{"key":"6482_CR74","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2106\/JBJS.D.03032","volume":"87","author":"CD Morris","year":"2005","unstructured":"Morris CD, Einhorn TA (2005) Bisphosphonates in orthopaedic surgery. J Bone Joint Surg Am 87:1609\u20131618. https:\/\/doi.org\/10.2106\/JBJS.D.03032","journal-title":"J Bone Joint Surg Am"},{"key":"6482_CR75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5606\/ehc.2016.03","volume":"27","author":"M T\u00fcrker","year":"2016","unstructured":"T\u00fcrker M, Aslan A, \u00c7\u0131rpar M et al (2016) Histological and biomechanical effects of zoledronate on fracture healing in an osteoporotic rat tibia model. Eklem Hastalik Cerrahisi 27:9\u201315. https:\/\/doi.org\/10.5606\/ehc.2016.03","journal-title":"Eklem Hastalik Cerrahisi"},{"key":"6482_CR76","first-page":"11","volume":"7","author":"TA Einhorn","year":"2010","unstructured":"Einhorn TA (2010) Can an anti-fracture agent heal fractures? Clin cases Miner bone Metab Off J Ital Soc Osteoporosis, Miner Metab Skelet Dis 7:11\u201314","journal-title":"Clin cases Miner bone Metab Off J Ital Soc Osteoporosis, Miner Metab Skelet Dis"},{"key":"6482_CR77","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2106\/JBJS.D.02115","volume":"87","author":"YM Alkhiary","year":"2005","unstructured":"Alkhiary YM, Gerstenfeld LC, Krall E et al (2005) Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1\u201334). J Bone Joint Surg Am 87:731\u2013741. https:\/\/doi.org\/10.2106\/JBJS.D.02115","journal-title":"J Bone Joint Surg Am"},{"key":"6482_CR78","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1359\/jbmr.070724","volume":"22","author":"S Kakar","year":"2007","unstructured":"Kakar S, Einhorn TA, Vora S et al (2007) Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J bone Miner Res Off J Am Soc Bone Miner Res 22:1903\u20131912. https:\/\/doi.org\/10.1359\/jbmr.070724","journal-title":"J bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"6482_CR79","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/bonekey.2016.86","volume":"5","author":"P Varga","year":"2016","unstructured":"Varga P, Hofmann-Fliri L, Blauth M, Windolf M (2016) Prophylactic augmentation of the osteoporotic proximal femur-mission impossible? Bonekey Rep 5:854. https:\/\/doi.org\/10.1038\/bonekey.2016.86","journal-title":"Bonekey Rep"},{"key":"6482_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster J-Y (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA 30:3\u201344. https:\/\/doi.org\/10.1007\/s00198-018-4704-5","journal-title":"Osteoporos Int J Establ Result Coop between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6482_CR81","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/jor.24239","volume":"37","author":"JD Stroncek","year":"2019","unstructured":"Stroncek JD, Shaul JL, Favell D et al (2019) In vitro injection of osteoporotic cadaveric femurs with a triphasic calcium-based implant confers immediate biomechanical integrity. J Orthop Res Off Publ Orthop Res Soc 37:908\u2013915. https:\/\/doi.org\/10.1002\/jor.24239","journal-title":"J Orthop Res Off Publ Orthop Res Soc"},{"key":"6482_CR82","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00198-019-05230-0","volume":"31","author":"JG Howe","year":"2020","unstructured":"Howe JG, Hill RS, Stroncek JD et al (2020) Treatment of bone loss in proximal femurs of postmenopausal osteoporotic women with AGN1 local osteo-enhancement procedure (LOEP) increases hip bone mineral density and hip strength: a long-term prospective cohort study. Osteoporos Int a J Establ as result Coop between Eur Found Osteoporos Natl Osteoporos Found USA 31:921\u2013929. https:\/\/doi.org\/10.1007\/s00198-019-05230-0","journal-title":"Osteoporos Int a J Establ as result Coop between Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"Suppl 4","key":"6482_CR83","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/s0020-1383(08)70003-2","volume":"38","author":"PV Giannoudis","year":"2007","unstructured":"Giannoudis PV, Einhorn TA, Marsh D (2007) Fracture healing: the diamond concept. Injury 38(Suppl 4):S3-6. https:\/\/doi.org\/10.1016\/s0020-1383(08)70003-2","journal-title":"Injury"},{"key":"6482_CR84","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00402-020-03382-x","volume":"140","author":"M Trost","year":"2020","unstructured":"Trost M, Schmoelz W, Wimmer D et al (2020) Local osteo-enhancement of osteoporotic vertebra with a triphasic bone implant material increases strength-a biomechanical study. Arch Orthop Trauma Surg 140:1395\u20131401. https:\/\/doi.org\/10.1007\/s00402-020-03382-x","journal-title":"Arch Orthop Trauma Surg"},{"key":"6482_CR85","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.clinbiomech.2014.02.001","volume":"29","author":"TN Tran","year":"2014","unstructured":"Tran TN, Warwas S, Haversath M et al (2014) Experimental and computational studies on the femoral fracture risk for advanced core decompression. Clin Biomech (Bristol, Avon) 29:412\u2013417. https:\/\/doi.org\/10.1016\/j.clinbiomech.2014.02.001","journal-title":"Clin Biomech (Bristol, Avon)"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06482-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-022-06482-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06482-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T09:07:57Z","timestamp":1668157677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-022-06482-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":85,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6482"],"URL":"https:\/\/doi.org\/10.1007\/s00198-022-06482-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"3 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"K-E. Akesson reports consultations and lecture fees from Amgen, Astellas Pharma, Chugai, RenaPharma, and UCB. M. Bouxsein serves on the Advisory Board for Keros Therapeutics and Beryl Health. M-L. Brandi has received honoraria from Amgen, Bruno Farmaceutici, Calcilytix, Kyowa Kirin, and UCB; reports grants and\/or speaker for Abiogen, AgNovosAlexion, Amgen, Bruno Farmaceutici, Echolight, Eli Lilly, Kyowa Kirin, SPA, Theramex, and UCB; and reports consultations for Aboca, Alexion, Amolyt, Bruno Farmaceutici, Calcilytix, Kyowa Kirin, and UCB. I. Cariati has no disclosures. R. Civinini reports personal fees and consultancy or lecture fees from Orthofix, Smith &Nephew, and Microport. F. Falez reports consultations for Lima, Microport, Adler, G21, and external collaborations for Menarini. E. Gasbarra has no disclosures. C. Greggi has no disclosures. G. Iolascon serves on the Advisory Board for UCB pharma, AMGEN, Eli-Lilly. R. Iundusi has no disclosures. A. Kurth serves on the advisory board for UCB, Amgen, and AgNovos; speaker fees from Amgen, Alexion, UCB, Eli-Lilly, Theramex, Ratiopharm, and AgNovos. P. Tranquilli Leali has no disclosures. U. Tarantino serves on the Advisory Board for Abiogen, AMGEN, Eli-Lilly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}